Acute pain management in the older adult is both challenging and rewarding. This review addresses the difficulty with assessment of pain in the older adult, variations in the pain experience of ...

“Today’s approval is an important public health milestone in acute pain management,” said Dr. Jacqueline Corrigan-Curay, acting director of the FDA's Center for Drug Evaluation and ...

ROCHESTER, N.Y. (WROC) – On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare providers ... it could act as a safer medication ...

Journavx became the first drug in a new class of pain management medications to be FDA approved. Image: Adobe Stock The approval “is an important public health milestone in acute pain management ...

“Today’s approval is an important public health milestone in acute pain management,” Jacqueline Corrigan-Curay, acting director of the FDA’s Center for Drug Evaluation and ...

When necessary, naloxone (an opioid antagonist) can be administered. Naloxone can cause opioid withdrawal, sudden severe pain, hypertension and pulmonary edema. The manufacturer of naloxone ...

we have the opportunity to change the paradigm of acute pain management and establish a new standard of care,” Kewalramani said. This approval was based on two randomized, double-blind, placebo- and ...

“Today’s approval is an important public health milestone in acute pain management,” said Dr. Jacqueline Corrigan-Curay, acting director of the FDA's Center for Drug Evaluation and Research, in a ...

“Today’s approval is an important public health milestone in acute pain management,” said Jacqueline Corrigan-Curay, MD, acting director of the FDA’s Center for Drug Evaluation and ...

“Today’s approval is an important public health milestone in acute pain management,” Jacqueline Corrigan-Curay, the acting director of the FDA's Center for Drug Evaluation and ...

First Drug Approved in New Class of Non-Opioid Pain Medicines; Agency Continues to Take Steps to Support New Approaches for Pain Management SILVER SPRING, Md., Jan. 30, 2025 /PRNewswire/ -- Today ...

Suzetrigine's approval highlights the ongoing need for effective non-opioid pain management solutions. Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years ...